Edwards Heart-Valve Guidance Lags On Medtronic, Boston Rivalry

Edwards Lifesciences' fiscal 2017 guidance lagged Wall Street for its heart-valve replacement tech amid fierce competition with Medtronic and Boston Scientific.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.